Comments

Plus Therapeutics

PSTVNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$1.66

0.074.40%

After Hours: 7:10 PM EDT

15 minutes delayed

Plus Therapeutics (PSTV) Forecast

News Earnings Guidance Dividends Analyst Ratings Insider Trades Short Interest

Plus Therapeutics (NASDAQ:PSTV) Stock Quotes, Forecast and News Summary

Plus Therapeutics Stock (NASDAQ: PSTV) stock price, news, charts, stock research, profile.

Open	$1.51
Close	-
Volume / Avg.	10.94K / 55.04K
Day Range	$1.50 - $1.61
52 Wk Range	0.97 - 2.78
Market Cap	$9.08M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	58
Short Interest	0.6%
Days to Cover	1

Recent News

Micro-Cap Brain Cancer Focused Plus Therapeutics Poised To Receive $3M From US Department of Defense

Plus Therapeutics will secure $3 million in funding from the Department of Defense for pediatric brain cancer trial expansion.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Plus Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, develo...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.